CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dugel Pravin −$233K Reporting owner sold <1% of stake
- Saroj Namrata −$232K Chief Business Officer sold 14% of stake
- Heier Jeffrey S. −$112K Chief Scientific Officer sold 4% of stake
- Kaiser Peter −$103K Chief Development Officer sold 5% of stake
- Anderman Todd −$87K Chief Legal Officer sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-14 | Heier Jeffrey S. Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-02-06 | White Christopher G Chief Business Officer | Sale | −5,829 | $4.24 | $25K | 94,766 |
| 2023-02-06 | Ozden Rabia Gurses Chief Medical Officer | Sale | −6,416 | $4.24 | $27K | 101,363 |
| 2023-02-06 | Notman Donald Chief Financial Officer | Sale | −6,476 | $4.24 | $27K | 139,387 |
| 2023-02-06 | Strassburger Philip C. General Counsel | Sale | −6,181 | $4.24 | $26K | 109,071 |
| 2023-02-06 | Mattessich Antony C. President and CEO | Sale | −19,669 | $4.24 | $83K | 446,281 |
| 2023-01-30 | White Christopher G Chief Business Officer | Grant or award | +44,444 | 100,595 | ||
| 2023-01-30 | White Christopher G Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +133,333 | 133,333 | ||
| 2023-01-30 | Strassburger Philip C. General Counsel | Grant or award | +55,556 | 115,252 | ||
| 2023-01-30 | Strassburger Philip C. General Counsel | Grant or award · Stock Option (Right to Buy) | +166,667 | 166,667 | ||
| 2023-01-30 | Ozden Rabia Gurses Chief Medical Officer | Grant or award | +55,556 | 107,779 | ||
| 2023-01-30 | Ozden Rabia Gurses Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +166,667 | 166,667 | ||
| 2023-01-30 | Ozden Rabia Gurses Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-01-30 | Notman Donald Chief Financial Officer | Grant or award | +55,556 | 145,863 | ||
| 2023-01-30 | Notman Donald Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +166,667 | 166,667 | ||
| 2023-01-30 | Mattessich Antony C. President and CEO | Grant or award | +176,300 | 465,950 | ||
| 2023-01-30 | Mattessich Antony C. President and CEO | Grant or award · Stock Option (Right to Buy) | +536,900 | 536,900 | ||
| 2022-11-07 | SUMMER ROAD LLC 10% owner | Purchase | +7,328 | $3.50 | $26K | 6,122,089 |
| 2022-10-17 | Heier Jeffrey S. Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2022-10-13 | White Christopher G Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 |
Page 11 of 17 · 327 trades